583 related articles for article (PubMed ID: 1349424)
1. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis.
Rothstein JD; Martin LJ; Kuncl RW
N Engl J Med; 1992 May; 326(22):1464-8. PubMed ID: 1349424
[TBL] [Abstract][Full Text] [Related]
2. The neuroexcitotoxic amino acids glutamate and aspartate are altered in the spinal cord and brain in amyotrophic lateral sclerosis.
Plaitakis A; Constantakakis E; Smith J
Ann Neurol; 1988 Sep; 24(3):446-9. PubMed ID: 2906529
[TBL] [Abstract][Full Text] [Related]
3. Pathways and genes differentially expressed in the motor cortex of patients with sporadic amyotrophic lateral sclerosis.
Lederer CW; Torrisi A; Pantelidou M; Santama N; Cavallaro S
BMC Genomics; 2007 Jan; 8():26. PubMed ID: 17244347
[TBL] [Abstract][Full Text] [Related]
4. [Free amino acid contents in the spinal cord of amyotrophic lateral sclerosis].
Fujita K; Nagata Y; Honda M
Rinsho Shinkeigaku; 1993 Sep; 33(9):985-7. PubMed ID: 7905368
[TBL] [Abstract][Full Text] [Related]
5. Chronic elevation of extracellular glutamate due to transport blockade is innocuous for spinal motoneurons in vivo.
Tovar-Y-Romo LB; Santa-Cruz LD; Zepeda A; Tapia R
Neurochem Int; 2009; 54(3-4):186-91. PubMed ID: 19100799
[TBL] [Abstract][Full Text] [Related]
6. Amyotrophic lateral sclerosis: amino acid levels in plasma and cerebrospinal fluid.
Perry TL; Krieger C; Hansen S; Eisen A
Ann Neurol; 1990 Jul; 28(1):12-7. PubMed ID: 2375629
[TBL] [Abstract][Full Text] [Related]
7. Impaired spinal cord glutamate transport capacity and reduced sensitivity to riluzole in a transgenic superoxide dismutase mutant rat model of amyotrophic lateral sclerosis.
Dunlop J; Beal McIlvain H; She Y; Howland DS
J Neurosci; 2003 Mar; 23(5):1688-96. PubMed ID: 12629173
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of genes in amyotrophic lateral sclerosis revealed by profiling the post mortem cortex.
Wang XS; Simmons Z; Liu W; Boyer PJ; Connor JR
Amyotroph Lateral Scler; 2006 Dec; 7(4):201-10. PubMed ID: 17127558
[TBL] [Abstract][Full Text] [Related]
9. p53 is abnormally elevated and active in the CNS of patients with amyotrophic lateral sclerosis.
Martin LJ
Neurobiol Dis; 2000 Dec; 7(6 Pt B):613-22. PubMed ID: 11114260
[TBL] [Abstract][Full Text] [Related]
10. Altered in-vitro and in-vivo expression of glial glutamate transporter-1 following exposure to cerebrospinal fluid of amyotrophic lateral sclerosis patients.
Shobha K; Vijayalakshmi K; Alladi PA; Nalini A; Sathyaprabha TN; Raju TR
J Neurol Sci; 2007 Mar; 254(1-2):9-16. PubMed ID: 17254611
[TBL] [Abstract][Full Text] [Related]
11. Beta-amyloid 42 accumulation in the lumbar spinal cord motor neurons of amyotrophic lateral sclerosis patients.
Calingasan NY; Chen J; Kiaei M; Beal MF
Neurobiol Dis; 2005; 19(1-2):340-7. PubMed ID: 15837590
[TBL] [Abstract][Full Text] [Related]
12. Cyanobacterial neurotoxin BMAA in ALS and Alzheimer's disease.
Pablo J; Banack SA; Cox PA; Johnson TE; Papapetropoulos S; Bradley WG; Buck A; Mash DC
Acta Neurol Scand; 2009 Oct; 120(4):216-25. PubMed ID: 19254284
[TBL] [Abstract][Full Text] [Related]
13. Increased internalisation and degradation of GLT-1 glial glutamate transporter in a cell model for familial amyotrophic lateral sclerosis (ALS).
Vanoni C; Massari S; Losa M; Carrega P; Perego C; Conforti L; Pietrini G
J Cell Sci; 2004 Oct; 117(Pt 22):5417-26. PubMed ID: 15466883
[TBL] [Abstract][Full Text] [Related]
14. Excitotoxicity and neurodegeneration in amyotrophic lateral sclerosis.
Rothstein JD
Clin Neurosci; 1995-1996; 3(6):348-59. PubMed ID: 9021256
[TBL] [Abstract][Full Text] [Related]
15. Selective up-regulation of the glial Na+-dependent glutamate transporter GLT1 by a neuroimmunophilin ligand results in neuroprotection.
Ganel R; Ho T; Maragakis NJ; Jackson M; Steiner JP; Rothstein JD
Neurobiol Dis; 2006 Mar; 21(3):556-67. PubMed ID: 16274998
[TBL] [Abstract][Full Text] [Related]
16. Abnormal glutamate metabolism in amyotrophic lateral sclerosis.
Plaitakis A; Caroscio JT
Ann Neurol; 1987 Nov; 22(5):575-9. PubMed ID: 2892463
[TBL] [Abstract][Full Text] [Related]
17. Persistent cleavage and nuclear translocation of apoptosis-inducing factor in motor neurons in the spinal cord of sporadic amyotrophic lateral sclerosis patients.
Shibata N; Kakita A; Takahashi H; Ihara Y; Nobukuni K; Fujimura H; Sakoda S; Sasaki S; Yamamoto T; Kobayashi M
Acta Neuropathol; 2009 Dec; 118(6):755-62. PubMed ID: 19669652
[TBL] [Abstract][Full Text] [Related]
18. Serotonergic mechanisms in amyotrophic lateral sclerosis.
Sandyk R
Int J Neurosci; 2006 Jul; 116(7):775-826. PubMed ID: 16861147
[TBL] [Abstract][Full Text] [Related]
19. Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis.
Heath PR; Shaw PJ
Muscle Nerve; 2002 Oct; 26(4):438-58. PubMed ID: 12362409
[TBL] [Abstract][Full Text] [Related]
20. Pigmented creatine deposits in Amyotrophic Lateral Sclerosis central nervous system tissues identified by synchrotron Fourier Transform Infrared microspectroscopy and X-ray fluorescence spectromicroscopy.
Kastyak MZ; Szczerbowska-Boruchowska M; Adamek D; Tomik B; Lankosz M; Gough KM
Neuroscience; 2010 Apr; 166(4):1119-28. PubMed ID: 20097271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
